186 related articles for article (PubMed ID: 20945500)
1. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
Bu H; Bormann S; Schäfer G; Horninger W; Massoner P; Neeb A; Lakshmanan VK; Maddalo D; Nestl A; Sültmann H; Cato AC; Klocker H
Prostate; 2011 May; 71(6):575-87. PubMed ID: 20945500
[TBL] [Abstract][Full Text] [Related]
2. Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
Bu H; Schweiger MR; Manke T; Wunderlich A; Timmermann B; Kerick M; Pasqualini L; Shehu E; Fuchsberger C; Cato AC; Klocker H
FEBS J; 2013 Mar; 280(5):1249-66. PubMed ID: 23294566
[TBL] [Abstract][Full Text] [Related]
3. Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.
Neeb A; Hefele S; Bormann S; Parson W; Adams F; Wolf P; Miernik A; Schoenthaler M; Kroenig M; Wilhelm K; Schultze-Seemann W; Nestel S; Schaefer G; Bu H; Klocker H; Nazarenko I; Cato AC
Oncotarget; 2014 Sep; 5(18):8681-9. PubMed ID: 25237833
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of anterior gradient gene AGR2 in prostate cancer.
Maresh EL; Mah V; Alavi M; Horvath S; Bagryanova L; Liebeskind ES; Knutzen LA; Zhou Y; Chia D; Liu AY; Goodglick L
BMC Cancer; 2010 Dec; 10():680. PubMed ID: 21144054
[TBL] [Abstract][Full Text] [Related]
5. Cancer-secreted AGR2 induces programmed cell death in normal cells.
Vitello EA; Quek SI; Kincaid H; Fuchs T; Crichton DJ; Troisch P; Liu AY
Oncotarget; 2016 Aug; 7(31):49425-49434. PubMed ID: 27283903
[TBL] [Abstract][Full Text] [Related]
6. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer.
Zhang JS; Gong A; Cheville JC; Smith DI; Young CY
Genes Chromosomes Cancer; 2005 Jul; 43(3):249-59. PubMed ID: 15834940
[TBL] [Abstract][Full Text] [Related]
7. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.
Zhang Y; Ali TZ; Zhou H; D'Souza DR; Lu Y; Jaffe J; Liu Z; Passaniti A; Hamburger AW
Cancer Res; 2010 Jan; 70(1):240-8. PubMed ID: 20048076
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer cell phenotypes based on AGR2 and CD10 expression.
Ho ME; Quek SI; True LD; Morrissey C; Corey E; Vessella RL; Dumpit R; Nelson PS; Maresh EL; Mah V; Alavi M; Kim SR; Bagryanova L; Horvath S; Chia D; Goodglick L; Liu AY
Mod Pathol; 2013 Jun; 26(6):849-59. PubMed ID: 23348903
[TBL] [Abstract][Full Text] [Related]
9. Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.
Kani K; Malihi PD; Jiang Y; Wang H; Wang Y; Ruderman DL; Agus DB; Mallick P; Gross ME
Prostate; 2013 Feb; 73(3):306-15. PubMed ID: 22911164
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients.
Zhang Y; Forootan SS; Liu D; Barraclough R; Foster CS; Rudland PS; Ke Y
Prostate Cancer Prostatic Dis; 2007; 10(3):293-300. PubMed ID: 17457305
[TBL] [Abstract][Full Text] [Related]
11. Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine.
Wayner EA; Quek SI; Ahmad R; Ho ME; Loprieno MA; Zhou Y; Ellis WJ; True LD; Liu AY
Prostate; 2012 Jun; 72(9):1023-34. PubMed ID: 22072305
[TBL] [Abstract][Full Text] [Related]
12. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
Salmans ML; Zhao F; Andersen B
Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006
[TBL] [Abstract][Full Text] [Related]
13. MS4A8B promotes cell proliferation in prostate cancer.
Ye L; Yao XD; Wan FN; Qu YY; Liu ZY; Shen XX; Li S; Liu XJ; Yue F; Wang N; Dai B; Ye DW
Prostate; 2014 Jun; 74(9):911-22. PubMed ID: 24789009
[TBL] [Abstract][Full Text] [Related]
14. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
[TBL] [Abstract][Full Text] [Related]
15. Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models.
Ateeq B; Vellaichamy A; Tomlins SA; Wang R; Cao Q; Lonigro RJ; Pienta KJ; Varambally S
Prostate; 2012 Oct; 72(14):1542-9. PubMed ID: 22415461
[TBL] [Abstract][Full Text] [Related]
16. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
17. Physiological stress induces the metastasis marker AGR2 in breast cancer cells.
Zweitzig DR; Smirnov DA; Connelly MC; Terstappen LW; O'Hara SM; Moran E
Mol Cell Biochem; 2007 Dec; 306(1-2):255-60. PubMed ID: 17694278
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
19. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
[TBL] [Abstract][Full Text] [Related]
20. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]